HMGCR and hypothyroidism: Future attention should be given to screening for epileptogenesis risk in the management of patients with ischemic stroke, hypothyroidism, high cholesterol, hypoglycemia, hypertension, low levels of 25(OH)D and testosterone, and those on long-term HMGCR inhibitors and β-blockers.